Vitamin K antagonist embryofetopathy
ORPHA:1914Malformation syndromeNot applicableAntenatal, Neonatal
Фенотипы (HPO)26
Очень частый (80–99%)5
HP:0000463Anteverted nares
HP:0003196Short nose
HP:0005280Depressed nasal bridge
HP:0008420Punctate vertebral calcifications
HP:0010655Epiphyseal stippling
Частый (30–79%)6
HP:0000470Short neck
HP:0001156Brachydactyly
HP:0001249Intellectual disability
HP:0001511Intrauterine growth retardation
HP:0002093Respiratory insufficiency
HP:0009882Short distal phalanx of finger
Периодический (5–29%)15
HP:0000158Macroglossia
HP:0000238Hydrocephalus
HP:0000316Hypertelorism
HP:0000365Hearing impairment
HP:0000453Choanal atresia
HP:0000505Visual impairment
HP:0000518Cataract
HP:0000520Proptosis
HP:0000648Optic atrophy
HP:0001250Seizure
HP:0001252Hypotonia
HP:0002475Myelomeningocele
HP:0008056Aplasia/Hypoplasia affecting the eye
HP:0008551Microtia
HP:0030680Abnormal cardiovascular system morphology
Эпидемиология1
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Point prevalence | Unknown | — | Worldwide | Class only |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)